James Mulshine to Neoplasm Proteins
This is a "connection" page, showing publications James Mulshine has written about Neoplasm Proteins.
Connection Strength
0.784
-
Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets. Bioinformatics. 2008 Feb 01; 24(3):389-95.
Score: 0.288
-
Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors. Cancer Res. 1999 May 01; 59(9):2223-8.
Score: 0.161
-
Peptide amidating activity in human bronchoalveolar lavage fluid. Lung Cancer. 1996 Jun; 14(2-3):239-51.
Score: 0.131
-
Transferrin dependence of Ga (NO3)3 inhibition of growth in human-derived small cell lung cancer cells. J Cell Biochem Suppl. 1996; 24:276-87.
Score: 0.128
-
Purification and characterization of a protein that permits early detection of lung cancer. Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4. J Biol Chem. 1996 May 03; 271(18):10760-6.
Score: 0.033
-
Monoclonal antibody alpha IR-3 inhibits non-small cell lung cancer growth in vitro and in vivo. J Cell Biochem Suppl. 1996; 24:269-75.
Score: 0.032
-
Alpha-amidation of peptide hormones in lung cancer. Cancer Cells. 1991 Dec; 3(12):504-10.
Score: 0.006
-
Biological, molecular, and clinical markers for the diagnosis and typing of lung cancer. Immunol Ser. 1990; 53:453-68.
Score: 0.005